# AmbioPharm, Inc - Inspection Records

Source: https://www.globalkeysolutions.net/companies/ambiopharm-inc/6a51f093-2f5b-433d-8e97-8e33820a50bf

> Inspection records and compliance data for AmbioPharm, Inc in Beech Island, South Carolina. Access full analysis and detailed observations.

---

## Details

- Name: AmbioPharm, Inc
- FEI Number: 3006446551
- City: Beech Island
- State: South Carolina
- Country Name: United States
- Address Line 1: 1024 Dittman Ct
- Zip Code: 29842
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING

## Related Documents

- [483 - AmbioPharm, Inc - 2023-02-09](https://www.globalkeysolutions.net/records/483/ambiopharm-inc/f5b141ab-3baf-4e5b-9481-6e991f46418e) — source: FDA, date: February 9, 2023
- [FDA Inspection 1196909 - AmbioPharm, Inc - 2023-02-09](https://www.globalkeysolutions.net/records/fda_inspections/ambiopharm-inc/1876e58a-256b-4566-b2d8-992e46cd34e2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 9, 2023
- [FDA Inspection 1018621 - AmbioPharm, Inc - 2017-07-05](https://www.globalkeysolutions.net/records/fda_inspections/ambiopharm-inc/034acc5a-11fe-467b-89ef-f72b1cbff8e4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 5, 2017
- [FDA Inspection 900896 - AmbioPharm, Inc - 2014-10-09](https://www.globalkeysolutions.net/records/fda_inspections/ambiopharm-inc/2c31fbf0-16c7-41b7-b568-fb6648633d40) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 9, 2014
- [FDA Inspection 826320 - AmbioPharm, Inc - 2013-03-28](https://www.globalkeysolutions.net/records/fda_inspections/ambiopharm-inc/7505087a-acba-4b31-a9a8-342523f51618) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 28, 2013
- [FDA Inspection 740844 - AmbioPharm, Inc - 2011-08-16](https://www.globalkeysolutions.net/records/fda_inspections/ambiopharm-inc/e1926746-404f-415a-a8df-9f60d082b689) — classification: No Action Indicated (NAI), source: FDA, date: August 16, 2011
- [FDA Inspection 546751 - AmbioPharm, Inc - 2008-11-04](https://www.globalkeysolutions.net/records/fda_inspections/ambiopharm-inc/7bb4244a-7ab1-466c-8ca4-185d3b62f95e) — classification: No Action Indicated (NAI), source: FDA, date: November 4, 2008

## Related Companies

- [PolyPeptide Laboratories, Inc.](https://www.globalkeysolutions.net/companies/polypeptide-laboratories-inc/9d05664c-4a42-45cc-81f6-ef85c356ecc1)
- [Sigma-Aldrich Manufacturing LLC](https://www.globalkeysolutions.net/companies/sigma-aldrich-manufacturing-llc/e6637246-5655-4a30-849d-a25e3a5cd06c)
- [Partner Therapeutics Inc](https://www.globalkeysolutions.net/companies/partner-therapeutics-inc/837081c1-0ffa-4c06-94c1-4ce65e130882)
- [MSD International GmbH](https://www.globalkeysolutions.net/companies/msd-international-gmbh/a9448cbd-d3cc-4427-a1d5-22dc511c3c07)
- [Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.](https://www.globalkeysolutions.net/companies/jiangsu-jiaerke-pharmaceuticals-group-corp-ltd/7ccd91ae-2b6a-43f7-acc5-6c182cec0d11)
- [SCI Pharmtech Inc.](https://www.globalkeysolutions.net/companies/sci-pharmtech-inc/38edf740-19b5-4fbf-bd65-e8cd87a7b1db)
- [Almac Sciences Limited](https://www.globalkeysolutions.net/companies/almac-sciences-limited/90ccdc83-facd-4798-aef2-460034d63adf)
- [Kyongbo Pharmaceutical Co., Ltd.](https://www.globalkeysolutions.net/companies/kyongbo-pharmaceutical-co-ltd/6b8fd90f-4fa3-4c7b-9ed6-a8a8f4b511da)
- [SAFC, Inc.](https://www.globalkeysolutions.net/companies/safc-inc/8b9b439f-c427-4b43-85d2-81ce982736be)
- [Signa S.A. de C.V.](https://www.globalkeysolutions.net/companies/signa-sa-de-cv/378a704e-5acb-49b8-9cd6-32503b29b3fc)

## Related Officers

- [Lilia M Lugo](https://www.globalkeysolutions.net/people/lilia-m-lugo/bd409997-f589-4d2d-b7ba-4b52f222e43e)